Every year nine million people globally get sick with TB. Unfortunately a third of them do not get the TB services that they deserve. Most of these three million people live in the world’s poorest and most vulnerable communities, including those in the African Region.

It is estimated that TB killed over half a million people in the Region in 2013. The threat of drug-resistant TB and multi-drug resistant TB continues to be a serious problem complicating TB treatment.

The TB epidemic in Africa is largely fuelled by poverty and the simultaneous infection with HIV. Poor people living with HIV are more likely than others to become sick with TB.

Countries in the Region are making efforts to cope with the challenges. According to the 2013 Global Tuberculosis Report, 55% of notified TB patients who tested positive for HIV in the Region also received WHO recommended antiretroviral treatment (ART).

The rising trend of TB cases has been halted and continues to decline as treatment success rate improves. Equally, the death rate as well as the number of people who fail to complete their TB treatment continues to decline.

Countries should continue to intensify efforts to fight HIV which is an important contributor to the TB epidemic. To reach the missing patients and move towards eliminating TB there is need to scale up TB interventions such as, DOTS and TB/HIV collaborative activities among others, especially for the most vulnerable groups. TB prevention and control activities should be targeted at areas such as slums, prisons and mines.

Objectives and functions

The objective of the TB Programme is to contribute to the reduction of the Tuberculosis (TB) disease burden in the WHO Africa Region through support to all member states to adopt and implement cost-effective TB prevention, treatment, care and support interventions in the context of strengthening Health system through the New Stop TB strategy

The Programme carries out the following functions:

  • Provides normative guidance and generic tools to member states for intensifying TB prevention and control efforts towards attainment of global, regional and national goals and targets;
  • Provides technical support to countries for accelerating and scaling up implementation of all interventions in the Stop TB strategy; especially strengthening core DOTS services, TB/HIV collaborative interventions, management of drug-resistant TB, and engagement of all care providers in the prevention and control of TB;
  • Supports countries in accessing and managing additional resources (including anti-TB medicines and other commodities) from global, regional and national partnerships for the fight against TB;
  • Provides technical support to member states for strengthening procurement & supply management systems and laboratory services and networks;
  • Supports member states to strengthen surveillance, monitoring and evaluation systems, assess the burden of TB and establish trends through periodic conduct of TB disease prevalence and tuberculin surveys;
  • Strengthens capacity for the conducting of operational research for evidence-based decision making.

Related links:

  1. WHO Stop TB Strategy
  2. OMS – Stratégie Halte à la tuberculose

For more information contact:

dr-kibugaDr Daniel Kibuga
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it